Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Non-Current Assets: 2011-2025

Historic Other Non-Current Assets for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $417,000.

  • Niagen Bioscience's Other Non-Current Assets rose 174.34% to $417,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $417,000, marking a year-over-year increase of 174.34%. This contributed to the annual value of $368,000 for FY2024, which is 142.11% up from last year.
  • Niagen Bioscience's Other Non-Current Assets amounted to $417,000 in Q3 2025, which was up 2.96% from $405,000 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Other Non-Current Assets registered a high of $69.0 million during Q1 2021, and its lowest value of $152,000 during Q4 2021.
  • For the 3-year period, Niagen Bioscience's Other Non-Current Assets averaged around $246,545, with its median value being $152,000 (2024).
  • In the last 5 years, Niagen Bioscience's Other Non-Current Assets skyrocketed by 8,502.62% in 2021 and then tumbled by 99.78% in 2022.
  • Niagen Bioscience's Other Non-Current Assets (Quarterly) stood at $152,000 in 2021, then remained steady at $152,000 in 2022, then remained steady at $152,000 in 2023, then soared by 142.11% to $368,000 in 2024, then surged by 174.34% to $417,000 in 2025.
  • Its Other Non-Current Assets stands at $417,000 for Q3 2025, versus $405,000 for Q2 2025 and $458,000 for Q1 2025.